Why Is Applied Therapeutics Stock Tanking Today?
Applied Therapeutics Inc APLT released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of progression to overt heart failure. The study's primary endpoint was stabilization or improvement in cardiac functional…
#arisehfphase3 #peakvo2 #bid #sglt2 #glp1 #aplt